Reynders McVeigh Capital Management’s Merck MRK Stock Holding History

Reynders McVeigh Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.69M	Sell	22,387 -705	-3%	-$81.4K	0.14%	69
2025 Q4	$2.43M	Sell	23,092 -184	-0.8%	-$17.3K	0.11%	68
2025 Q3	$1.95M	Sell	23,276 -1,458	-6%	-$120K	0.09%	77
2025 Q2	$1.96M	Sell	24,734 -1,569	-6%	-$125K	0.1%	78
2025 Q1	$2.36M	Sell	26,303 -1,211	-4%	-$113K	0.13%	73
2024 Q4	$2.74M	Sell	27,514 -2,263	-8%	-$233K	0.14%	70
2024 Q3	$3.38M	Buy	29,777 +390	+1%	+$46.3K	0.18%	66
2024 Q2	$3.64M	Buy	29,387 +1,397	+5%	+$180K	0.21%	62
2024 Q1	$3.69M	Sell	27,990 -15,695	-36%	-$1.93M	0.21%	61
2023 Q4	$4.76M	Sell	43,685 -569	-1%	-$59.1K	0.3%	58
2023 Q3	$4.56M	Sell	44,254 -551	-1%	-$59.4K	0.31%	52
2023 Q2	$5.17M	Buy	44,805 +3,012	+7%	+$342K	0.34%	48
2023 Q1	$4.45M	Sell	41,793 -1,061	-2%	-$115K	0.31%	49
2022 Q4	$4.75M	Sell	42,854 -1,386	-3%	-$142K	0.35%	48
2022 Q3	$3.81M	Sell	44,240 -1,059	-2%	-$94.5K	0.3%	53
2022 Q2	$4.13M	Sell	45,299 -1,923	-4%	-$170K	0.31%	53
2022 Q1	$3.88M	Sell	47,222 -1,922	-4%	-$152K	0.24%	58
2021 Q4	$3.77M	Sell	49,144 -971	-2%	-$77.3K	0.21%	59
2021 Q3	$3.76M	Sell	50,115 -4,320	-8%	-$329K	0.23%	57
2021 Q2	$4.23M	Sell	54,435 -13,983	-20%	-$1.04M	0.26%	54
2021 Q1	$5.03M	Sell	68,418 -3,085	-4%	-$228K	0.34%	49
2020 Q4	$5.58M	Sell	71,503 -1,953	-3%	-$149K	0.38%	46
2020 Q3	$5.81M	Sell	73,456 -2,129	-3%	-$167K	0.45%	44
2020 Q2	$5.58M	Buy	75,585 +2,157	+3%	+$162K	0.49%	42
2020 Q1	$5.39M	Buy	73,428 +613	+0.8%	+$48.2K	0.61%	38
2019 Q4	$6.32M	Sell	72,815 -4,816	-6%	-$396K	0.61%	37
2019 Q3	$6.24M	Sell	77,631 -10	-0%	-$801	0.67%	36
2019 Q2	$6.21M	Sell	77,641 -1,762	-2%	-$135K	0.67%	36
2019 Q1	$6.3M	Buy	79,403 +11,575	+17%	+$866K	0.7%	34
2018 Q4	$4.95M	Buy	67,828 +20,771	+44%	+$1.47M	0.66%	37
2018 Q3	$3.19M	Sell	47,057 -961	-2%	-$61.2K	0.37%	56
2018 Q2	$2.78M	Buy	48,018 +2,543	+6%	+$143K	0.35%	57
2018 Q1	$2.36M	Sell	45,475 -540	-1%	-$29.2K	0.3%	59
2017 Q4	$2.47M	Sell	46,015 -1,152	-2%	-$63.9K	0.32%	57
2017 Q3	$2.88M	Sell	47,167 -3,511	-7%	-$213K	0.38%	51
2017 Q2	$3.1M	Sell	50,678 -629	-1%	-$38.3K	0.41%	51
2017 Q1	$3.11M	Sell	51,307 -2,963	-5%	-$180K	0.43%	52
2016 Q4	$3.05M	Buy	54,270 +2,616	+5%	+$153K	0.43%	50
2016 Q3	$3.08M	Buy	51,654 +251	+0.5%	+$14.7K	0.45%	44
2016 Q2	$2.83M	Buy	51,403 +2,514	+5%	+$134K	0.41%	46
2016 Q1	$2.47M	Buy	48,889 +2,500	+5%	+$122K	0.37%	52
2015 Q4	$2.34M	Buy	46,389 +996	+2%	+$50.2K	0.38%	45
2015 Q3	$2.14M	Sell	45,393 -1,199	-3%	-$63.7K	0.37%	49
2015 Q2	$2.53M	Buy	46,592 +3,716	+9%	+$208K	0.41%	45
2015 Q1	$2.35M	Sell	42,876 -120	-0.3%	-$6.79K	0.4%	44
2014 Q4	$2.33M	Buy	42,996 +627	+1%	+$34.9K	0.41%	45
2014 Q3	$2.4M	Buy	42,369 +839	+2%	+$47.1K	0.46%	45
2014 Q2	$2.29M	Buy	41,530 +1,393	+3%	+$76K	0.52%	44
2014 Q1	$2.17M	Sell	40,137 -861	-2%	-$44.6K	0.51%	45
2013 Q4	$1.96M	Sell	40,998 -200	-0.5%	-$9.14K	0.48%	49
2013 Q3	$1.87M	Sell	41,198 -3,212	-7%	-$147K	0.52%	49
2013 Q2	$1.97M	Buy	+44,410	New	+$1.98M	0.58%	42

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reynders McVeigh Capital Management's MRK Position: Q1 2026 in Review

Reynders McVeigh Capital Management reduced its Merck (MRK) stake by 3.1% in Q1 2026, selling an estimated $81.4K and leaving 22,387 shares worth $2.69M. The position accounts for 0.14% of the portfolio, ranked #69.

Reynders McVeigh Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.32M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Reynders McVeigh Capital Management held 22,387 shares of Merck worth $2.69M as of Q1 2026.
Reynders McVeigh Capital Management sold 705 Merck shares in Q1 2026, an estimated $81.4K.
Merck made up 0.14% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #69 holding.
Reynders McVeigh Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Reynders McVeigh Capital Management's Merck position peaked at $6.32M in Q4 2019.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.